CST
BMY icon

Charles Schwab Trust’s Bristol-Myers Squibb BMY Stock Holding History

Charles Schwab Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
3,775
+400
+12% +$23K 0.01% 165
2026
Q1 		$205K Sell
3,375
-1,541
-31% -$89.8K 0.01% 159
2025
Q4 		$265K Buy
4,916
+10
+0.2% +$481 0.02% 160
2025
Q3 		$221K Buy
4,906
+171
+4% +$7.99K 0.02% 171
2025
Q2 		$219K Buy
4,735
+69
+1% +$3.39K 0.02% 170
2025
Q1 		$285K Buy
+4,666
New +$272K 0.02% 150
2024
Q1 		– Sell
-5,021
Closed -$258K – 158
2023
Q4 		$258K Buy
5,021
+35
+0.7% +$1.84K 0.03% 150
2023
Q3 		$289K Sell
4,986
-67
-1% -$4.11K 0.03% 143
2023
Q2 		$326K Sell
5,053
-2,433
-33% -$163K 0.04% 115
2023
Q1 		$519K Sell
7,486
-3,363
-31% -$237K 0.06% 97
2022
Q4 		$781K Hold
10,849
– – 0.1% 85
2022
Q3 		$771K Hold
10,849
– – 0.13% 83
2022
Q2 		$835K Buy
10,849
+147
+1% +$11.2K 0.17% 77
2022
Q1 		$782K Sell
10,702
-3,080
-22% -$207K 0.14% 84
2021
Q4 		$859K Sell
13,782
-303
-2% -$17.8K 0.14% 87
2021
Q3 		$833K Buy
14,085
+303
+2% +$20K 0.16% 95
2021
Q2 		$921K Sell
13,782
-64
-0.5% -$4.17K 0.18% 87
2021
Q1 		$871K Sell
13,846
-8,089
-37% -$503K 0.18% 89
2020
Q4 		$1.36M Buy
21,935
+8,205
+60% +$505K 0.33% 68
2020
Q3 		$828K Sell
13,730
-639
-4% -$38.5K 0.25% 75
2020
Q2 		$843K Buy
14,369
+829
+6% +$49.6K 0.28% 71
2020
Q1 		$755K Sell
13,540
-175
-1% -$10.7K 0.31% 71
2019
Q4 		$880K Buy
13,715
+5,107
+59% +$292K 0.34% 70
2019
Q3 		$436K Buy
+8,608
New +$405K 0.2% 88

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Charles Schwab Trust's BMY Position: Q2 2026 in Review

Charles Schwab Trust increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $23K and bringing the position to 3,775 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #165.

Charles Schwab Trust first reported a position in BMY in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.36M in Q4 2020. 714 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Charles Schwab Trust held 3,775 shares of Bristol-Myers Squibb worth $218K as of Q2 2026.
  • Charles Schwab Trust bought 400 Bristol-Myers Squibb shares in Q2 2026, an estimated $23K.
  • Bristol-Myers Squibb made up 0.01% of Charles Schwab Trust's portfolio in Q2 2026, its #165 holding.
  • Charles Schwab Trust first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 24 quarters since.
  • Charles Schwab Trust's Bristol-Myers Squibb position peaked at $1.36M in Q4 2020.
  • 714 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.